ArticleHuman vaccines & immunotherapeutics2024

Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer.

Tommaso P Tonelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.